Frank Mccormick
Director at Bridgebio Pharma · 11 reported transactions in 1 company · latest trade Oct 29, 2025
Their trades
Sold | Oct 29, 2025 | Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days. | ||
Sold | Oct 29, 2025 | Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days. | ||
Sold | Oct 29, 2025 | Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days. | ||
Sold | Oct 29, 2025 | Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days. | ||
Sold | Oct 29, 2025 | Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days. | ||
Sold | Oct 27, 2025 | Oct 27, 2025 close $63.56 → Oct 26, 2026 close $68.15. S&P 500 +11.7% over the same days. | ||
Sold | Sep 5, 2025 | Sep 5, 2025 close $53.38 → Oct 26, 2026 close $68.15. S&P 500 +18.3% over the same days. | ||
Sold | Jun 24, 2025 | Jun 24, 2025 close $44.45 → Oct 26, 2026 close $68.15. S&P 500 +26.1% over the same days. |
SoldBridgebio Pharma
$3M
Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days.
SoldBridgebio Pharma
$589K
Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days.
SoldBridgebio Pharma
$236.1K
Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days.
SoldBridgebio Pharma
$2.06M
Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days.
SoldBridgebio Pharma
$7.32M
Oct 29, 2025 close $66.62 → Oct 26, 2026 close $68.15. S&P 500 +11.3% over the same days.
SoldBridgebio Pharma
$106.7K
Oct 27, 2025 close $63.56 → Oct 26, 2026 close $68.15. S&P 500 +11.7% over the same days.
SoldBridgebio Pharma
$3.93M
Sep 5, 2025 close $53.38 → Oct 26, 2026 close $68.15. S&P 500 +18.3% over the same days.
SoldBridgebio Pharma
$4.42M
Jun 24, 2025 close $44.45 → Oct 26, 2026 close $68.15. S&P 500 +26.1% over the same days.